50419-0171 Stivarga - CanMED: NDC

Product NDC:

50419-0171

Brand Name:

Stivarga

Generic Name:

Regorafenib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: REGORAFENIB MONOHYDRATE

Strength: 40.0

Unit: mg/1

Packages:

Code: 50419-0171-00

Description: 210 BOTTLE in 1 BOX (50419-171-00) / 28 TABLET, FILM COATED in 1 BOTTLE

Effective Date: Sept. 27, 2012

Discontinued:

Code: 50419-0171-01

Description:

Effective Date: Sept. 27, 2012

Discontinued:

Code: 50419-0171-03

Description: 3 BOTTLE, PLASTIC in 1 BOX (50419-171-03) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-01)

Effective Date: Sept. 27, 2012

Discontinued:

Code: 50419-0171-04

Description: 1 BOTTLE, PLASTIC in 1 CARTON (50419-171-04) / 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC

Effective Date: Sept. 27, 2012

Discontinued:

Code: 50419-0171-06

Description: 4 BOTTLE, PLASTIC in 1 CARTON (50419-171-06) / 21 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-171-05)

Effective Date: May 1, 2021

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

VEGF, FGF, PDGFR, KIT, RET, TIE2, DDR2, TrkQ, RAF, BRAF, SAPK2, PTK, Abl

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox